Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
INTS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FETUB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIPT-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IQCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506538 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUSC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC25C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPARC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM170B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on